Albert Bourla, Pfizer CEO (Laurent Gillieron/Keystone via AP Images)

Fol­low­ing FDA, CHMP gives thumbs-up on Pfiz­er, BioN­Tech Omi­cron boost­er

One day af­ter the FDA cleared Pfiz­er’s bi­va­lent boost­er to go af­ter Omi­cron, the phar­ma gi­ant and its part­ners at BioN­Tech are now one step …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.